Presentation schedule

 

 

Click on the links below to view abstracts and posters presented at this congress. All copyright remains that of the copyright holder. This page will be available for a limited period after the congress.

Poster presentations
Thursday 4 October 2018

12:00–13:00  PS 059: On the efficacy of GLP1 receptor agonists Poster Hall

13:15–14:15  PS 078: Hypoglycaemia rates with basal insulin  Poster Hall

Poster presentation 837 Bain

Effects of IDegLira (insulin degludec/liraglutide) in patients with poorly controlled type 2 diabetes with HbA1c >9%: analyses from the DUAL programme

  View PDF

Poster presentation 838 Jaeckel

Lower day-to-day fasting self-measured plasma glucose (SMPG) variability with insulin degludec/liraglutide (IDegLira) vs. insulin glargine 100 units/ml (IGlar U100)

  View PDF

Poster presentation 839 Brod

Patient-reported outcomes for insulin degludec/liraglutide vs. insulin glargine as add-on to sodium-glucose co-transporter-2 inhibitor in type 2 diabetes: DUAL IX trial

  View PDF

Poster presentation 840 Meneghini

Patients with type 2 diabetes on the maximum dose of insulin degludec/liraglutide (IDegLira) achieve glycaemic target: analyses from the DUAL programme

  View PDF

Poster presentation 841 Janez

IDegLira improves glycaemic control in subjects with type 2 diabetes uncontrolled on basal insulin without deterioration despite discontinuing pre-trial sulphonylurea

  View PDF